BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 2790679)

  • 1. DNA cytofluorometric and nuclear morphometric analyses of lung adenocarcinoma.
    Asamura H; Nakajima T; Mukai K; Noguchi M; Shimosato Y
    Cancer; 1989 Oct; 64(8):1657-64. PubMed ID: 2790679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nuclear DNA content by cytofluorometry of stage I adenocarcinoma of the lung in relation to postoperative recurrence.
    Asamura H; Nakajima T; Mukai K; Shimosato Y
    Chest; 1989 Aug; 96(2):312-8. PubMed ID: 2752813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clonal growth of atypical adenomatous hyperplasia of the lung: cytofluorometric analysis of nuclear DNA content.
    Nakayama H; Noguchi M; Tsuchiya R; Kodama T; Shimosato Y
    Mod Pathol; 1990 May; 3(3):314-20. PubMed ID: 2362938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histopathologic prognostic factors in resected adenocarcinomas: is nuclear DNA content prognostic?
    Asamura H; Ando M; Matsuno Y; Shimosato Y
    Chest; 1999 Apr; 115(4):1018-24. PubMed ID: 10208203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differentiation of atypical adenomatous hyperplasia and adenocarcinoma of the lung by use of DNA ploidy and morphometric analysis.
    Yokozaki M; Kodama T; Yokose T; Matsumoto T; Mukai K
    Mod Pathol; 1996 Dec; 9(12):1156-64. PubMed ID: 8972475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor cell heterogeneity and subpopulations with metastatic ability in differentiated adenocarcinoma of the lung. Histologic and cytofluorometric DNA analyses.
    Nomori H; Hirohashi S; Noguchi M; Matsuno Y; Shimosato Y
    Chest; 1991 Apr; 99(4):934-40. PubMed ID: 2009798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Intratumoral heterogeneity of DNA content in lung adenocarcinoma].
    Miura H; Taira O; Hiraguri S; Hagiwara M; Kato H
    Jpn J Thorac Cardiovasc Surg; 1998 Aug; 46(8):712-8. PubMed ID: 9785868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic and therapeutic significance of the flow cytometric nuclear DNA content in non-small cell lung cancer.
    Isobe H; Miyamoto H; Shimizu T; Haneda H; Hashimoto M; Inoue K; Mizuno S; Kawakami Y
    Cancer; 1990 Mar; 65(6):1391-5. PubMed ID: 2155055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA image cytometric analysis of differentiated thyroid adenocarcinoma specimens.
    Camargo RS; Scafuri AG; de Tolosa EM; Ferreira EA
    Am J Surg; 1992 Dec; 164(6):640-5. PubMed ID: 1463115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluorescence cytophotometric measurements of nuclear DNA in adenocarcinoma of the lung; relation of proliferative activity and DNA ploidy to prognosis.
    Blöndal T; Lindgren A
    Anal Quant Cytol; 1982 Sep; 4(3):225-32. PubMed ID: 7149488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of tumor size and tumor cell DNA content on the survival of patients with stage I adenocarcinoma of the lung.
    Cibas ES; Melamed MR; Zaman MB; Kimmel M
    Cancer; 1989 Apr; 63(8):1552-6. PubMed ID: 2924263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship of nuclear DNA content to clinicopathologic features in colorectal cancer.
    Lanza G; Maestri I; Ballotta MR; Dubini A; Cavazzini L
    Mod Pathol; 1994 Feb; 7(2):161-5. PubMed ID: 8008736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Degree of malignancy of thymic epithelial tumors in terms of nuclear DNA content and nuclear area. An analysis of 39 cases.
    Asamura H; Nakajima T; Mukai K; Noguchi M; Shimosato Y
    Am J Pathol; 1988 Dec; 133(3):615-22. PubMed ID: 3202120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of nuclear DNA content and expression of the ras oncogene product in lung cancer.
    Miyamoto H; Harada M; Isobe H; Akita HD; Haneda H; Yamaguchi E; Kuzumaki N; Kawakami Y
    Cancer Res; 1991 Dec; 51(23 Pt 1):6346-50. PubMed ID: 1657384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Flow-cytometric analysis of nuclear DNA content in endometrial adenocarcinoma. Atypical mitoses are associated with DNA aneuploidy.
    Genest DR; Sheets E; Lage JM
    Am J Clin Pathol; 1994 Sep; 102(3):341-8. PubMed ID: 8085558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Flow cytometric analysis of cellular DNA content of lung cancer with reference to survival].
    Shiota T; Konishi T; Kosaba S; Mitsuoka A; Matsubara Y; Hatakenaka R; Funatsu T; Ikeda S; Matsumoto H; Ishigami F
    Nihon Kyobu Geka Gakkai Zasshi; 1990 Dec; 38(12):2364-9. PubMed ID: 2290045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA content in prostatic adenocarcinoma. A flow cytometry study of the predictive value of aneuploidy for tumor volume, percentage Gleason grade 4 and 5, and lymph node metastases.
    Jones EC; McNeal J; Bruchovsky N; de Jong G
    Cancer; 1990 Aug; 66(4):752-7. PubMed ID: 2386903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prognostic significance of the nuclear DNA content of a small adenocarcinoma of the lung].
    Isobe H; Shimizu T; Miyamoto H; Kawakami Y; Okayasu K; Hashimoto M; Shimizu M; Endo T; Inoue K; Mizuno S
    Gan No Rinsho; 1988 Oct; 34(12):1667-71. PubMed ID: 3193611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [An analysis of nuclear DNA histogram of adenocarcinoma of the uterine cervix].
    Yoshida K
    Nihon Sanka Fujinka Gakkai Zasshi; 1989 Jun; 41(6):723-8. PubMed ID: 2768967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nuclear DNA content as a prognostic predictor in carcinoma of the pancreas.
    Yoshimura T; Manabe T; Suwa H; Imamura T; Wang Z; Ohshio G; Yamabe H; Matsumoto M; Ogasahara K; Takasan H
    Int J Pancreatol; 1993 Aug; 14(1):29-36. PubMed ID: 8409574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.